175 related articles for article (PubMed ID: 15492565)
1. A new prognostic staging system for rectal cancer.
Ueno H; Price AB; Wilkinson KH; Jass JR; Mochizuki H; Talbot IC
Ann Surg; 2004 Nov; 240(5):832-9. PubMed ID: 15492565
[TBL] [Abstract][Full Text] [Related]
2. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.
Ueno H; Murphy J; Jass JR; Mochizuki H; Talbot IC
Histopathology; 2002 Feb; 40(2):127-32. PubMed ID: 11952856
[TBL] [Abstract][Full Text] [Related]
3. Tumor budding as a prognostic marker in stage-III rectal carcinoma.
Choi HJ; Park KJ; Shin JS; Roh MS; Kwon HC; Lee HS
Int J Colorectal Dis; 2007 Aug; 22(8):863-8. PubMed ID: 17216219
[TBL] [Abstract][Full Text] [Related]
4. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
Okuyama T; Oya M; Ishikawa H
J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
[TBL] [Abstract][Full Text] [Related]
5. Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy.
Du C; Xue W; Li J; Cai Y; Gu J
Hum Pathol; 2012 Jul; 43(7):1061-7. PubMed ID: 22204710
[TBL] [Abstract][Full Text] [Related]
6. A new prognostic classification of rectal cancer.
Jass JR; Love SB; Northover JM
Lancet; 1987 Jun; 1(8545):1303-6. PubMed ID: 2884421
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
8. Surgeon-related factors and outcome in rectal cancer.
Porter GA; Soskolne CL; Yakimets WW; Newman SC
Ann Surg; 1998 Feb; 227(2):157-67. PubMed ID: 9488510
[TBL] [Abstract][Full Text] [Related]
9. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer.
Mace AG; Pai RK; Stocchi L; Kalady MF
Dis Colon Rectum; 2015 Jan; 58(1):32-44. PubMed ID: 25489692
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
Roy P; Serra S; Kennedy E; Chetty R
J Surg Oncol; 2012 Feb; 105(2):130-4. PubMed ID: 21842520
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
[TBL] [Abstract][Full Text] [Related]
12. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma.
Michelassi F; Ayala JJ; Balestracci T; Goldberg R; Chappell R; Block GE
Ann Surg; 1991 Jul; 214(1):11-8. PubMed ID: 2064465
[TBL] [Abstract][Full Text] [Related]
13. Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.
Demir A; Alan O; Oruc E
World J Surg Oncol; 2019 Mar; 17(1):50. PubMed ID: 30871581
[TBL] [Abstract][Full Text] [Related]
14. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
[TBL] [Abstract][Full Text] [Related]
16. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
17. Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response.
Kim HJ; Jo JS; Lee SY; Kim CH; Kim YJ; Kim HR
Ann Surg Oncol; 2015; 22(6):2075-81. PubMed ID: 25395150
[TBL] [Abstract][Full Text] [Related]
18. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
20. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
